Drug intelligence / Profile preview

gemfibrozil + red yeast rice

Development stage
Unknown
Lead developer
National Taiwan University Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Gemfibrozil + red yeast rice is a combination of the fibric acid derivative gemfibrozil and the dietary supplement red yeast rice (specifically the LipoCol Forte brand). Gemfibrozil functions as a PPAR-alpha agonist, primarily used to lower serum triglycerides and increase HDL cholesterol. Red yeast rice is a fermented product of Monascus purpureus that contains monacolin K, which is chemically identical to the statin lovastatin and acts as an HMG-CoA reductase inhibitor to lower LDL cholesterol. This specific combination was the subject of a Phase 1 clinical pharmacokinetic study conducted by National Taiwan University Hospital to evaluate the safety and potential drug-drug interactions between the two agents, as concomitant use of fibrates and statins is known to increase the risk of myopathy and rhabdomyolysis.

Brand names
LopidLipoCol Forte
Other names
gemfibrozil + Monascus purpureusgemfibrozil + LipoCol
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)PPARA (Peroxisome proliferator-activated receptor alpha)PPARD (Peroxisome proliferator–activated receptor delta)

Beyond the preview

Go deeper on gemfibrozil + red yeast rice.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gemfibrozil + red yeast rice.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call